Famotidine Tablets, 40 mg
Phase 1Completed 0 views this week 0 watching💤 Quiet
Interest: 23/100
23
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Bioavailability
Conditions
Bioavailability
Trial Timeline
Jun 1, 2004 → —
NCT ID
NCT00803192About Famotidine Tablets, 40 mg
Famotidine Tablets, 40 mg is a phase 1 stage product being developed by Perrigo for Bioavailability. The current trial status is completed. This product is registered under clinical trial identifier NCT00803192. Target conditions include Bioavailability.
Hype Score Breakdown
Clinical
6
Activity
8
Company
9
Novelty
0
Community
0
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00803192 | Phase 1 | Completed |
| NCT00802828 | Phase 1 | Completed |
Competing Products
20 competing products in Bioavailability